Anlotinib inhibits growth of human esophageal cancer TE-1 cells by negative regulating PI3K/Akt signaling pathway
Article in Discover Oncology (April 2024)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Article in Discover Oncology (April 2024)
Article in Frontiers in Molecular Biosciences (March 2024)
Article in Molecular Biology Reports (January 2024)